{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/la-fda-aprueba-mounjaro-tirzepatida-de-lilly-para-reducir-el-riesgo-cardiovascular-en-adultos-con-diabetes-tipo-2-843973142.html", "message": "News view counter 906947 successfully enlarged"}